Research: Paragazole makes triple-negative breast cancer cells express estrogen recep

[News]

Breast cancers that lack estrogen receptors are more difficult to treat than ER+ cancers. Research presented at the AACR Annual Meeting 2013 demonstrates an investigational drug, Paragazole, that makes triple-negative breast cancer cells express estrogen receptors, and that increases the sensitivity of these cells to chemotherapy.

More... (http://www.news-medical.net/news/20130409/Research-Paragazole-makes-triple-negative-breast-cancer-cells-express-estrogen-receptors.aspx)